Physician profile
Bashar Samman
NPI 1558322743
$1,413.40
in general payments reported to CMS, 2019-2025
21 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $31.02 · 2021: $11.36 · 2022: $167 · 2023: $349 · 2024: $311 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $607.76 | 2019-2025 | |
| Boston Scientific Corporation | $144.61 | 2023-2025 | Watchman Flx, Watchman Access System |
| Amgen INC. | $91.45 | 2023-2025 | Repatha, Repatha |
| Preventice Services, LLC | $82.40 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $67.97 | 2022-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $59.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.80 | 2022-2023 | Jardiance |
| Ge Healthcare | $47.43 | 2025 | |
| W. L. Gore & Associates, INC. | $41.64 | 2019 | |
| Irhythm Technologies, INC. | $31.68 | 2022-2023 | Zio Xt Patch |
| Novo Nordisk INC | $24.08 | 2024 | Wegovy |
| Abiomed | $22.92 | 2025 | |
| Inari Medical, INC. | $20.51 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $19.66 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.49 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $17.74 | 2019 | |
| Philips North America LLC | $17.36 | 2023 | |
| Baxter Healthcare | $15.23 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $14.31 | 2024 | Camzyos |
| Abbott Laboratories | $11.37 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $9.30 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Samman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.